These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 27430936)
21. Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis. Ji C; Hu J; Wang X; Zheng W; Deng X; Song H; Yu Y; Luo Q; Hua K; Zhou X; Fang L Aging (Albany NY); 2021 Mar; 13(7):9627-9645. PubMed ID: 33744861 [TBL] [Abstract][Full Text] [Related]
22. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. Wang PC; Weng CC; Hou YS; Jian SF; Fang KT; Hou MF; Cheng KH Int J Mol Sci; 2014 Feb; 15(3):3560-79. PubMed ID: 24583847 [TBL] [Abstract][Full Text] [Related]
23. TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Epping MT; Meijer LA; Krijgsman O; Bos JL; Pandolfi PP; Bernards R Nat Cell Biol; 2011 Jan; 13(1):102-8. PubMed ID: 21170034 [TBL] [Abstract][Full Text] [Related]
24. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. Wang L; Zhao W; Zhang M; Wang P; Zhao K; Zhao X; Yang S; Gao C J Virol; 2013 Apr; 87(8):4507-15. PubMed ID: 23388719 [TBL] [Abstract][Full Text] [Related]
25. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029 [TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy. He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030 [TBL] [Abstract][Full Text] [Related]
27. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo. Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163 [TBL] [Abstract][Full Text] [Related]
28. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression. Tao Y; You W Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860 [TBL] [Abstract][Full Text] [Related]
29. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Fan YH; Yu Y; Mao RF; Tan XJ; Xu GF; Zhang H; Lu XB; Fu SB; Yang J Cell Death Differ; 2011 Oct; 18(10):1547-60. PubMed ID: 21331078 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis. Zhu L; Yang S; He S; Qiang F; Cai J; Liu R; Gu C; Guo Z; Wang C; Zhang W; Zhang C; Wang Y J Mol Histol; 2016 Feb; 47(1):69-80. PubMed ID: 26712154 [TBL] [Abstract][Full Text] [Related]
31. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Santhanam AN; Baker AR; Hegamyer G; Kirschmann DA; Colburn NH Oncogene; 2010 Jul; 29(27):3921-32. PubMed ID: 20498644 [TBL] [Abstract][Full Text] [Related]
32. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer. Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883 [TBL] [Abstract][Full Text] [Related]
33. Structural basis for recruiting and shuttling of the spliceosomal deubiquitinase USP4 by SART3. Park JK; Das T; Song EJ; Kim EE Nucleic Acids Res; 2016 Jun; 44(11):5424-37. PubMed ID: 27060135 [TBL] [Abstract][Full Text] [Related]
34. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells. Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367 [TBL] [Abstract][Full Text] [Related]
35. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1. Zhang H; Han Y; Xiao W; Gao Y; Sui Z; Ren P; Meng F; Tang P; Yu Z Cell Death Dis; 2023 Nov; 14(11):730. PubMed ID: 37949874 [TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65. Hwang SK; Baker AR; Young MR; Colburn NH Carcinogenesis; 2014 Jul; 35(7):1469-80. PubMed ID: 24413684 [TBL] [Abstract][Full Text] [Related]
37. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures. Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208 [TBL] [Abstract][Full Text] [Related]
38. Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation. Schmid T; Bajer MM; Blees JS; Eifler LK; Milke L; Rübsamen D; Schulz K; Weigert A; Baker AR; Colburn NH; Brüne B Carcinogenesis; 2011 Oct; 32(10):1427-33. PubMed ID: 21771721 [TBL] [Abstract][Full Text] [Related]
39. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer. Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468 [TBL] [Abstract][Full Text] [Related]
40. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]